6,6'-Dimethyl 5,5'-dibromo-2H,2'H,3H,3'H-[1,1'-biindole]-6,6'-dicarboxylate, 97%, 1g

2-(1H-Indol-3-yl)-2-methylpropan-1-amine hydrochloride, 95.0%, 1g

2-Bromo-5-iodoethylbenzene, 95+%, 250mg

1-Ethyl-3-(4-nitrophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 98%, 500mg

Gránulos de oro, mínimo 99,95 %, 1-6 mm, 5 g, envase de vidrio

3,4-difluoro-2'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone, 97.0%, 1g

3,4,5-Trifluorobenzoyl chloride, 97.0%, 25g

1,8-Bis(2-pyridyl)-3,6-dithiaoctane>98.0%(GC)(T)5g

2-(5-amino-3-methyl-1H-pyrazol-1-yl)-5,6-dimethylpyrimidin-4(3H)-one, 95.0%, 500mg

2,4-Difluorobenzenesulfonyl chloride, 98.0%, 1g

6-Methyl-4-pyrimidinamine, 95.0%, 100mg

(5r,7r)-2-Bromo-7-fluoro-5-phenyl-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,4]triazole, 98%, 250mg

(S)-N-((3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, 95.0%, 25g